Fibrin(ogen) Structure and Interactions

纤维蛋白（原）结构和相互作用

• 批准号: 7526954
• 负责人: LEONID V. MEDVED
• 金额: $ 37.5万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-01-01 至 2012-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7526954
• 关键词: Amyloidosis; Binding Sites; Biochemical; Blood Clot; Blood coagulation; Bos taurus; C-terminal; Cattle; Coagulation Process; Complex; Condition; Congenital Abnormality; Data; Defect; Development; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostatic function; Human; Individual; Inflammation; Inherited; Kidney; Kidney Diseases; Knowledge; Laboratories; Mediating; Methods; Molecular; Molecular Conformation; Mutation; N-terminal; Numbers; Pathologic Processes; Pathology; Pharmacia brand of estropipate; Physiological; Plasma Proteins; Play; Polymers; Preparation; Process; Proteins; Public Health; Pulmonary Embolism; Recombinants; Recurrence; Research; Resolution; Role; Solutions; Structure; Testing; Thrombin; Thrombosis; Variant; Wound Healing; angiogenesis; atherogenesis; base; cell type; intermolecular interaction

DESCRIPTION (provided by applicant): Fibrinogen is a multidomain polyfunctional plasma protein that after thrombin-mediated conversion into fibrin plays a prominent role in a number of important physiological and pathological processes, including hemostasis, thrombosis, wound healing, inflammation, angiogenesis, and atherogenesis. Better understanding of the mechanisms underlying these processes requires establishment of the structure and interactions of this complex molecule. The long-term objectives of our research are to generate comprehensive knowledge on the structure of fibrinogen and fibrin and to establish the molecular mechanisms of their multiple interactions with various proteins and cell types. Significant progress has been made in understanding the fibrinogen structure in the last decade. However, the structural organization of the C-terminal portions of its A1 chains (1C- domains) and the N-terminal portions of its B2 chains (B2N-domains) is still unclear. Numerous data suggest that the conformation of the 1C-domains in fibrinogen may differ from that in fibrin, in which they form 1C- polymers and become highly reactive. Still, the molecular mechanisms of 1C-polymer formation remain to be established. This application focuses on the 1C-domains, which are involved in fibrin assembly, fibrin- dependent fibrinolysis, angiogenesis, atherogenesis, and renal amyloidosis. The first Specific Aim is to establish the NMR solution structure of the isolated fibrinogen 1C-domain, to elucidate the structural organization of this domain in fibrin 1C-polymers, and to clarify the structural basis for hereditary renal amyloidosis caused by mutations in the 1C-domain region. The second Specific Aim is to elucidate the molecular mechanisms of the intra- and intermolecular interactions of the 1C-domains, which are responsible for the formation of physiologically active 1C-polymers in fibrin, and for the pathological consequences of their acquired and congenital defects. These aims will be accomplished by preparation of recombinant 1C-domain fragments and their truncated variants, as well as recombinant and proteolitically obtained fragments that represent the central region of fibrin(ogen) with the (B)2N-domains, and studying their structure and numerous interactions by biochemical and biophysical methods. The proposed studies will generate basic knowledge that will have an impact on our understanding of the molecular mechanisms underlying formation of fibrin clots in normal and pathological conditions and ability to control the above mentioned fibrin-dependent processes. Because acquired and congenital defects in the 1C-domains may cause severe pathological consequences, including hemorrhage, various thrombotic disorders, and renal amyloidosis, the proposed studies will also further clarify the molecular mechanisms underlying these pathologies, and thereby contribute to the development of their therapies. PUBLIC HEALTH RELEVANCE: The proposed studies will generate basic knowledge about the structure and function of individual domains of fibrin(ogen), the major component of the blood coagulation cascade. Such knowledge is required to better understand and control the molecular mechanisms underlying the fibrin(ogen)-dependent processes, such as blood clotting, fibrinolysis, inflammation, and angiogenesis. Because congenital and acquired defects in these domains may cause severe pathological consequences, including hemorrhage, various thrombotic disorders, and renal amyloidosis, the proposed studies will further clarify the molecular mechanisms underlying these pathologies, and thereby contribute to the development of their therapies.

描述(申请人提供)：纤维蛋白原是一种多结构域的多功能血浆蛋白，在凝血酶介导的转化为纤维蛋白后，在许多重要的生理和病理过程中发挥重要作用，包括止血、血栓形成、伤口愈合、炎症、血管生成和动脉粥样硬化。要更好地理解这些过程背后的机制，就需要建立这种复杂分子的结构和相互作用。我们研究的长期目标是对纤维蛋白原和纤维蛋白的结构产生全面的了解，并建立它们与各种蛋白质和细胞类型多重相互作用的分子机制。在过去的十年里，在了解纤维蛋白原结构方面取得了重大进展。然而，其A1链的C-末端部分(1C-结构域)和其B2链的N-末端部分(B2N-结构域)的结构组织仍不清楚。大量数据表明，纤维蛋白原中1C结构域的构象可能与纤维蛋白中的不同，在纤维蛋白中它们形成1C聚合物并变得高度活性。尽管如此，1C-聚合物形成的分子机制仍有待确定。这一应用主要集中在1C结构域上，这些结构域参与纤维蛋白组装、纤维蛋白依赖的纤溶、血管生成、动脉粥样硬化和肾脏淀粉样变性。第一个具体目的是建立分离的纤维蛋白原1C结构域的核磁共振溶液结构，阐明该结构域在纤维蛋白1C聚合物中的结构组织，并阐明1C结构域突变导致遗传性肾淀粉样变性的结构基础。第二个具体目的是阐明1C结构域的分子内和分子间相互作用的分子机制，这些1C结构域负责在纤维蛋白中形成具有生理活性的1C聚合物，以及它们后天和先天缺陷的病理后果。这些目标将通过制备重组的1C结构域片段及其截断的变体，以及代表纤维蛋白(原)的中心区与(B)2N结构域的重组和蛋白质组学获得的片段，并通过生化和生物物理方法研究它们的结构和众多相互作用来实现。拟议中的研究将产生基础知识，将影响我们对正常和病理条件下纤维蛋白凝块形成的分子机制的理解，以及控制上述纤维蛋白依赖过程的能力。由于1C结构域的获得性和先天性缺陷可能导致严重的病理后果，包括出血、各种血栓性疾病和肾脏淀粉样变性，因此拟议的研究也将进一步阐明这些病理基础的分子机制，从而有助于其治疗的发展。公共卫生相关性：拟议的研究将产生关于纤维蛋白(原)各个区域的结构和功能的基本知识，纤维蛋白(原)是凝血级联反应的主要组成部分。这些知识是更好地理解和控制纤维蛋白(原)依赖过程的分子机制所必需的，如凝血、纤溶、炎症和血管生成。由于这些区域的先天性和获得性缺陷可能导致严重的病理后果，包括出血、各种血栓性疾病和肾脏淀粉样变性，因此拟议的研究将进一步阐明这些病理基础的分子机制，从而有助于它们的治疗方法的发展。